Krka, d. d. (LJSE:KRKG)

Market Cap	5.31B
Revenue (ttm)	1.91B
Net Income (ttm)	356.99M
Shares Out	30.60M
EPS (ttm)	11.60
PE Ratio	14.96
Forward PE	14.58
Dividend	7.50 (4.37%)
Ex-Dividend Date	Jul 23, 2024

Volume	3,758
Average Volume	7,622
Open	171.00
Previous Close	171.50
Day's Range	171.00 - 173.50
52-Week Range	123.50 - 174.00
Beta	0.50
RSI	58.45
Earnings Date	Apr 10, 2025

About Krka, d. d.

Krka, d. d., a generic pharmaceutical company, develops, produces, markets, and sells prescription pharmaceuticals, non-prescription products, and animal health products in Slovenia, South-East Europe, East Europe, Central Europe, West Europe, and internationally. The company’s prescription pharmaceuticals include medicines for the treatment of cardiovascular, gastrointestinal tract and metabolism, central nervous system, infections, oncology, and other diseases. It provides non-prescription products for oral cavity and pharynx; cough and cold;...

• Industry: Pharmaceutical Preparations
• Founded: 1954
• Employees: 12,810
• Stock Exchange: Ljubljana Stock Exchange
• Ticker Symbol: KRKG

Financial Performance

In 2024, Krka, d. d.'s revenue was 1.91 billion, an increase of 5.71% compared to the previous year's 1.81 billion. Earnings were 356.99 million, an increase of 13.71%.